X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (358) 358
humans (247) 247
timolol (230) 230
glaucoma (202) 202
ophthalmology (190) 190
animals (138) 138
male (133) 133
pharmacology & pharmacy (133) 133
female (111) 111
intraocular pressure - drug effects (106) 106
timolol maleate (104) 104
glaucoma - drug therapy (101) 101
open-angle glaucoma (97) 97
timolol - administration & dosage (91) 91
benzalkonium chloride (79) 79
aged (74) 74
middle aged (74) 74
rabbits (71) 71
timolol - therapeutic use (71) 71
latanoprost (70) 70
intraocular-pressure (69) 69
intraocular pressure (65) 65
ocular hypertension (58) 58
drugs (56) 56
glaucoma, open-angle - drug therapy (56) 56
timolol - pharmacology (56) 56
hypertension (55) 55
administration, topical (54) 54
adult (54) 54
ophthalmic solutions (53) 53
antihypertensive agents - administration & dosage (52) 52
ocular hypertension - drug therapy (52) 52
eye diseases (50) 50
timolol - adverse effects (50) 50
genetic structures (47) 47
ophthalmic drugs (45) 45
toxicity (45) 45
drug delivery systems (44) 44
drug therapy (43) 43
in-vitro (43) 43
analysis (42) 42
drug combinations (41) 41
sense organs (39) 39
adrenergic beta-antagonists - administration & dosage (38) 38
antihypertensive agents - adverse effects (38) 38
antihypertensive agents - therapeutic use (38) 38
travoprost (38) 38
abridged index medicus (36) 36
efficacy (36) 36
treatment outcome (35) 35
adrenergic beta-antagonists - therapeutic use (33) 33
prospective studies (33) 33
safety (33) 33
aged, 80 and over (32) 32
medicine & public health (32) 32
timolol - pharmacokinetics (32) 32
drug therapy, combination (31) 31
therapy (31) 31
care and treatment (30) 30
dorzolamide (30) 30
ocular surface (30) 30
research (30) 30
pharmacology/toxicology (29) 29
brimonidine (28) 28
eye (28) 28
vehicles (28) 28
ophthalmic solutions - administration & dosage (27) 27
cornea (26) 26
double-blind method (26) 26
brimonidine tartrate (25) 25
dose-response relationship, drug (25) 25
internal medicine (25) 25
medication (25) 25
preservatives (25) 25
timolol - toxicity (25) 25
adrenergic beta-antagonists - adverse effects (24) 24
biological availability (24) 24
cell survival - drug effects (24) 24
conjunctiva - drug effects (24) 24
cloprostenol - analogs & derivatives (23) 23
cornea - metabolism (23) 23
medicine, research & experimental (23) 23
adrenergic beta-antagonists - pharmacology (22) 22
beta-blockers (22) 22
bioavailability (22) 22
hydrogels (22) 22
permeability (22) 22
rats (22) 22
surgery (22) 22
time factors (22) 22
apoptosis (21) 21
bimatoprost (21) 21
cells, cultured (21) 21
contact lenses (21) 21
eye drops (21) 21
ophthalmic solutions - adverse effects (21) 21
release (21) 21
betaxolol (20) 20
cell line (20) 20
cornea - drug effects (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical & Experimental Ophthalmology, ISSN 1442-6404, 08/2008, Volume 36, Issue 6, pp. 553 - 559
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
AAPS PharmSciTech, ISSN 1530-9932, 12/2011, Volume 12, Issue 4, pp. 1087 - 1101
In the present study, an effort was made to design prolonged release Eudragit nanoparticles of brimonidine tartrate by double emulsion–solvent evaporation... 
Biochemistry, general | Biotechnology | Biomedicine | nanoparticles | intraocular pressure | brimonidine tartrate | Pharmacy | glaucoma | Pharmacology/Toxicology | Eudragit | DRUG-DELIVERY | ALGINATE | CHITOSAN NANOPARTICLES | TOXICITY | TIMOLOL | DISPOSITION | ACID NANOPARTICLES | NANOSPHERES | PHARMACOLOGY & PHARMACY | RABBIT | Administration, Ophthalmic | Intraocular Pressure - drug effects | Adrenergic alpha-2 Receptor Agonists - chemistry | Adrenergic alpha-2 Receptor Agonists - pharmacology | Drug Carriers | Dose-Response Relationship, Drug | Nanoparticles | Quinoxalines - pharmacology | Adrenergic alpha-2 Receptor Agonists - administration & dosage | Quinoxalines - toxicity | Drug Compounding | Glaucoma - physiopathology | Disease Models, Animal | Rabbits | Quinoxalines - administration & dosage | Drug Stability | Solubility | Quinoxalines - chemistry | Glaucoma - drug therapy | Technology, Pharmaceutical - methods | Brimonidine Tartrate | Acrylic Resins - chemistry | Chemistry, Pharmaceutical | Adrenergic alpha-2 Receptor Agonists - toxicity | Animals | Acrylic Resins - toxicity | Kinetics | Delayed-Action Preparations | Nanotechnology | Hydrogen-Ion Concentration | Drugs | Glaucoma | Drug delivery systems | Lecithin | Sulfonamides | Sympathomimetic agents | Brimonidine | Dosage and administration | Plant lipids | Ophthalmology | Vehicles | Drugstores | Indexing in process | Index Medicus
Journal Article
Advances in Therapy, ISSN 0741-238X, 6/2011, Volume 28, Issue 6, pp. 501 - 510
Journal Article